Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | SNCA | P37840 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | TTR | P02766 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | GPR35 | Q9HC97 | 4/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8214082 | 0.81 | ALDH1A1 (0.44) | ALDH1A1MAPTSNCAPOLBTTR | |
| SCHEMBL9812448 | 0.81 | GPR35 (0.57) | ALDH1A1MAPTTTRKDM4EGPR35 | |
| SCHEMBL11566427 | 0.79 | GPR35 (0.52) | ALDH1A1MAPTSNCAPOLBGPR35 | |
| SCHEMBL1667914 | 0.79 | ALDH1A1 (0.50) | ALDH1A1MAPTSNCAPOLBTTR | |
| SCHEMBL8848416 | 0.76 | TTR (0.58) | ALDH1A1MAPTTTRKDM4EGPR35 | |
| SCHEMBL6810374 | 0.76 | ALDH1A1 (0.41) | ALDH1A1MAPTSNCAPOLBTTR | |
| SCHEMBL515466 | 0.75 | MAPT (0.54) | ALDH1A1MAPTSNCAPOLBTTR | |
| SCHEMBL9812439 | 0.75 | KDM4E (0.53) | ALDH1A1MAPTSNCATTRKDM4E | |
| SCHEMBL6918424 | 0.73 | MAPT (0.37) | ALDH1A1MAPTSNCAPOLBTTR | |
| SCHEMBL3596934 | 0.73 | TSHR (0.46) | ALDH1A1MAPTTTRKDM4EGPR35 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6815567-B2 | MANUFACTURING OF MOLECULAR ELECTRONIC DEVICE, NITRATION, ESTERIFICATION, HYDROLYSIS, SULFIDING | ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE (KR) | 2004-11-09 | — | — | US | disclosed |
| US-20040147786-A1 | Derivatives of 4-sulfanylalkyl-3,5-dinitrobenzyl alcohol and method for preparing the same | ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE (KR) | 2004-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040147786-A1 | Derivatives of 4-sulfanylalkyl-3,5-dinitrobenzyl alcohol and method for preparing the same | ADH1A, ADH1C, ADH5 | ALDH1A1 6/4885MAPT 4755/4885SNCA 1140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.